Alimera Sciences Inc (ALIM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -4,968 | -18,107 | -14,327 | -9,070 | -5,955 |
| Depreciation Amortization | 963 | 3,859 | 2,876 | 1,911 | 960 |
| Income taxes - deferred | N/A | 116 | N/A | N/A | N/A |
| Accounts receivable | 430 | -863 | -963 | -1,725 | 184 |
| Accounts payable and accrued liabilities | -434 | 1,468 | 428 | -880 | -1,992 |
| Other Working Capital | 700 | 2,689 | 485 | -1,418 | -1,974 |
| Other Operating Activity | 1,100 | 863 | 1,777 | 3,371 | 2,564 |
| Operating Cash Flow | $-2,209 | $-9,975 | $-9,724 | $-7,811 | $-6,213 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -9 | -255 | -171 | -41 | -149 |
| Investing Cash Flow | $-9 | $-255 | $-171 | $-41 | $-149 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 2,500 | N/A | 0 | 0 | 0 |
| Debt Repayment | -127 | -289 | -164 | -204 | -62 |
| Common Stock Issued | 0 | 100 | 55 | 40 | N/A |
| Common Stock Repurchased | -314 | N/A | 0 | 0 | 0 |
| Other Financing Activity | 7,939 | -113 | 0 | 0 | 0 |
| Financing Cash Flow | $9,998 | $-302 | $-109 | $-164 | $-62 |
| Exchange Rate Effect | 33 | -708 | -998 | -638 | -141 |
| Beginning Cash Position | 5,304 | 16,544 | 16,544 | 16,544 | 16,544 |
| End Cash Position | 13,117 | 5,304 | 5,542 | 7,890 | 9,979 |
| Net Cash Flow | $7,813 | $-11,240 | $-11,002 | $-8,654 | $-6,565 |
| Free Cash Flow | |||||
| Operating Cash Flow | -2,209 | -9,975 | -9,724 | -7,811 | -6,213 |
| Capital Expenditure | -9 | -255 | -171 | -41 | -149 |
| Free Cash Flow | -2,218 | -10,230 | -9,895 | -7,852 | -6,362 |